Castle Biosciences (CSTL): Aggregate Business Value
This daily price action for Castle Biosciences (CSTL) reflects an Enterprise Value of 824.10. Castle Biosciences develops high-precision molecular tests for oncologists that minimize the number of surgical interventions. The company implements its environmental development strategy through the digitalization of document workflows and the use of biodegradable packaging. The company is strengthening its human capital by hiring laboratory specialists and implementing a long-term incentive system for leading scientists.
CSTL (Castle Biosciences): analytical breakdowns and indicator data
An investor assesses the operational resilience of Castle Biosciences (CSTL) through the aggregate value of all assets. High-margin DecisionDx genomic tests create the foundation for the business's capitalization. Historical EV dynamics combine the market value of shares with debt minus cash, determining the actual buyout price. This calculation neutralizes price volatility, revealing the balance between liquidity and yield. This confirms the fundamental strength of Castle Biosciences (CSTL).